DNA

Touchlight and GSK Sign License Agreement for DNA Production

Touchlight, a UK-based custom development and manufacturing organization (CDMO) specializing in enzymatic DNA production, signed a license agreement with British drugmaker GSK which grants GSK non-exclusive rights to use Touchlight’s proprietary enzymatic dbDNA (doggybone DNA) technology for the development and production of mRNA-based products.

Agilent Contracts Turner for Frederick API Project

Agilent Technologies has selected Turner Construction to build its previously announced new API plant in Frederick, Colorado, USA. The project is scheduled for completion in 2026.

Lonza and Touchlight Collaborate on DNA

Lonza has entered into a collaboration with Touchlight, a biotechnology company with patented technology for producing enzymatic DNA. The enzymatic manufacturing process is said to enable GMP production at “unprecented speed, scale and purity.”

Innovative Companies Have to Deal with Risks

Ginkgo Bioworks Buys Synthetic DNA Firm Gen9

Judge in New York Dismisses Human Gene Patent

UK Scientists Find Cheap, Fast Gene Test Method